A phase I trial of OBE 022 in healthy volunteers

Trial Profile

A phase I trial of OBE 022 in healthy volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 13 Jan 2017

At a glance

  • Drugs OBE 022 (Primary)
  • Indications Preterm labour
  • Focus Adverse reactions; First in man; Pharmacokinetics
  • Most Recent Events

    • 13 Jan 2017 Results published in an ObsEva media release.
    • 13 Jan 2017 Status changed from recruiting to completed, as per an ObsEva media release.
    • 05 Aug 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top